IFPMA Director General concerned about future antibiotics: The pipeline looks "grim"
Thomas Cueni, director general at the global trade association IFPMA uses the word "grim" to describe the antibacterial pipeline currently under clinical development. He hopes this picture can be changed through the newly established antibiotics fund, AMR Action Fund.
BY KEVIN GRØNNEMANN, TRANSLATED BY NIELSINE NIELSEN
Antibacterial products under clinical development right now that constitute our future hope in the battle against bacteria, are not altogether an encouraging sight.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
